Company intelligence / Profile preview

Lusochimica

Lomagna, Lombardy, Italylusochimica.it ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Lusochimica manufactures and supplies a broad range of commercialized active pharmaceutical ingredients (APIs) in compliance with international cGMP standards. Their APIs are used globally in marketed drugs across several therapeutic areas including cardiovascular disease, respiratory conditions, dermatology and diabetes[1][5][6].

Therapeutic areas: PulmonologyCardiovascularEndocrinologyInfectious Diseases
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Lusochimica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lusochimica.

Explore the full profile